Your session is about to expire
← Back to Search
Cortical Access System
MICAS for Chronic Subdural Hematoma
N/A
Waitlist Available
Led By Jamie Van Gompel, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Must be 55 years of age or greater.
Have a clinically symptomatic chronic subdural hematoma greater than 1 cm in maximal thickness and be judged clinically to need subdural evacuation.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 years
Awards & highlights
Study Summary
This trial is testing a new, less-invasive way to remove old blood from the space between the brain and its membrane.
Who is the study for?
This trial is for individuals aged 55 or older who have a chronic subdural hematoma (a type of brain bleed) that's more than 1 cm thick and needs draining. Participants must be able to give consent, not belong to a vulnerable group, not require ongoing blood thinners, and cannot be pregnant or have had prior surgery for this condition.Check my eligibility
What is being tested?
The study is testing the Minimally Invasive Cortical Access System (MICAS), which aims to offer a less invasive way to remove old blood from beneath the skull's inner layer compared to current methods.See study design
What are the potential side effects?
Potential side effects are not explicitly listed but may include risks associated with minimally invasive brain procedures such as infection, bleeding, neurological deficits, and reactions specific to the MICAS device.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 55 years old or older.
Select...
I have a significant brain bleed needing surgery.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Incidence of all serious adverse events
Trial Design
1Treatment groups
Experimental Treatment
Group I: Treatment GroupExperimental Treatment1 Intervention
During clinically indicated surgery for subdural hematoma, the patient will undergo a single burr hole evacuation with the MICAS device with endoscopic assistance.
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,242 Previous Clinical Trials
3,773,743 Total Patients Enrolled
Jamie Van Gompel, MDPrincipal InvestigatorMayo Clinic
Share this study with friends
Copy Link
Messenger